@article {Abadeerbcr2016217840, author = {Kerolos Abadeer and Ali A Alsaad and Xochiquetzal J Geiger and Ivan E Porter}, title = {Collapsing glomerulopathy in systemic lupus erythematosus}, volume = {2017}, elocation-id = {bcr2016217840}, year = {2017}, doi = {10.1136/bcr-2016-217840}, publisher = {BMJ Publishing Group}, abstract = {Collapsing glomerulopathy (CG) is a rare disease that can be associated with multiple other disorders. It usually leads to poor prognosis with a high percentage of patients progressing to end-stage renal disease. In this article, we illustrate a clinical case of CG associated with systemic lupus erythematosus that had a prompt response to mycophenolate and prednisone. The condition started after sudden cessation of the already established mycophenolate treatment regimen. The patient then presented with acute kidney injury due to kidney biopsy-proven CG. In that circumstance, we hypothesised that mycophenolate may play a role in prevention and development of CG.}, URL = {https://casereports.bmj.com/content/2017/bcr-2016-217840}, eprint = {https://casereports.bmj.com/content/2017/bcr-2016-217840.full.pdf}, journal = {Case Reports} }